Akums Lifesciences Ltd. is a vertically integrated company that develops, manufactures, and sells Active Pharmaceutical Ingredients (API), High Potency API, and API intermediates. Our unique research and synthesis facility reflects our commitment to research and innovation. The world-class manufacturing facilities at Akums are spread across 3 locations in India, one unit in Haryana and two in Punjab. These facilities are benchmarked to international standards and set to meet the rigorous quality guideline (ICH-Q series, Eudralex, WHO & PIC’s), which is critical in achieving our global growth aspirations.
As a leading API supplier, our regulatory-approved facilities enable us to supply our partners across 51 countries with a broad portfolio of products. Our expertise spans a variety of chemical processes, including Beta Lactams (Cephalosphorin and Penem), Heterocyclic chemistry, Carbohydrates chemistry, Steroids & stereochemistry. Additionally, we manage enzyme conversions for some of our products. Our manufacturing capacity for various categories ranges from 750MT/year to 1200MT/Year.
Akums continues to invest substantial resources towards sustaining and continuously improving the standards of environment, occupational health and safety as it believes that its responsibility towards the society and the environment extends beyond those laid down by the regulatory authorities.
We have a development facility in Barwala-Haryana, India. Our strong scientific capabilities in synthetic chemistry,analytical chemistry and process engineering......View more
Our capabilities include multistep synthesis & scale-up. We have the expertise to perform versatile chemical reactions, route scouting, process development.....View more
Akums Lifesciences has experienced global regulatory expertise focused on international markets. Our top-class quality and CGMP compliance are designed to ensure our products.......View more
Dedicated to manufacturing Beta-lactam range of API’s Capacity of ~1,00MT/year of Cephalosporin range of API’s 90KL reaction capacity equipped to carry out a multistep synthesis. A total of 9 production suites is spread over 98,900 sq. Meter.
Non-beta-lactam facility manufacturing 30+ APIs 150 KL reaction capacity with 3 manufacturing plants equipped with 6 clean rooms spread over 73,100 Sq. Meter. Facility is fully compliant with the latest EHS norms with zero liquid discharge facility.
Facility is spread over 8,600 Sq Meter located in HSIDC industrial area. Facility comprises state-of-art R&D center for development & contract research & custom synthesis. Facility also has a separate small volume, highly potent CGMP API manufacturing facility for oncology & other OEB5 level synthesis.